Novel Experimental Therapeutic Approaches in Glioma—New Hydrazide–Hydrazones as Chemical Agents Sensitizing Glioblastoma Cell Line to Radiotherapy
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27125459 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Dorota Natorska-Chomicka und 7 weiteren Autor:innen. Beteiligte Einrichtung: Chair and Department of Toxicology, Faculty of Pharmacy, Medical University of Lublin, 8B Jaczewskiego Str., 20-090 Lublin, Poland. Hauptthemen laut MEDLINE: Hydrazones, Glioblastoma, Radiation-Sensitizing Agents, Hydrazines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Gliomas are highly aggressive tumors of the nervous system and remain difficult to treat with currently available therapeutic approaches. Due to their poor prognosis and resistance to standard treatments, there is a growing need for novel strategies, including therapies based on the combined use of radiotherapy and chemotherapy. The aim of this study was to evaluate the potential of newly synthesized hydrazide–hydrazones to sensitize glioblastoma tumor cells to X-ray irradiation. Two novel hydrazide–hydrazones of 5-bromo-2-iodobenzoic acid (3 and 4) were synthesized on the basis of condensation reaction. The chemical structure of obtained compounds was established with the use of IR, 1H NMR and 13C NMR spectroscopy. In vitro biological studies demonstrated that the radiosensitizing effect of the tested hydrazide–hydrazones was strongly dependent on both compound concentration and glioblastoma cell line. In LN-229 cells, compound 3 at 164 μM combined with 2 Gy irradiation reduced cell viability by 65% and increased the subG1 population, indicating enhanced cytotoxicity and induction of cell death. Similarly, compound 4 at 242 μM combined with 2–5 Gy irradiation decreased LN-229 cell viability by more than 50% and promoted cell cycle arrest and apoptosis, whereas both compounds showed limited or even proliferative effects in U-87MG cells, highlighting the importance of tumor-specific biological characteristics in determining treatment response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chair and Department of Toxicology, Faculty of Pharmacy, Medical University of Lublin, 8B Jaczewskiego Str., 20-090 Lublin, Poland.
- Chair and Department of Organic Chemistry, Faculty of Pharmacy, Medical University of Lublin, 4A Chodźki Str., 20-093 Lublin, Poland.
ORCID-Profile: Monika Gawrońska-Grzywacz
Zitieren
APA
Natorska-Chomicka, D., Gawrońska-Grzywacz, M., Patrejko, P., Herbet, M., Piątkowska-Chmiel, I., Iwan, M., Dudka, J., & Popiołek, Ł. (2026). Novel Experimental Therapeutic Approaches in Glioma—New Hydrazide–Hydrazones as Chemical Agents Sensitizing Glioblastoma Cell Line to Radiotherapy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27125459
Vancouver
Natorska-Chomicka D, Gawrońska-Grzywacz M, Patrejko P, Herbet M, Piątkowska-Chmiel I, Iwan M, et al. Novel Experimental Therapeutic Approaches in Glioma—New Hydrazide–Hydrazones as Chemical Agents Sensitizing Glioblastoma Cell Line to Radiotherapy. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27125459
BibTeX
@article{NatorskaChomicka2026,
author = {Natorska-Chomicka, Dorota and Gawrońska-Grzywacz, Monika and Patrejko, Paweł and Herbet, Mariola and Piątkowska-Chmiel, Iwona and Iwan, Magdalena and Dudka, Jarosław and Popiołek, Łukasz},
title = {Novel Experimental Therapeutic Approaches in Glioma—New Hydrazide–Hydrazones as Chemical Agents Sensitizing Glioblastoma Cell Line to Radiotherapy},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27125459}
}
EUVIMED